PANK1 and metabolic dysfunction-associated steatohepatitis: Inhibition of pantothenate kinase activity reduces hepatic levels of CoA and acetyl-CoA synthesis, leading to TCAC uncoupling, lipotoxic intermediates accumulation, and electron leakage, which are well-known mechanisms of lipotoxicity, oxidative stress, and NASH progression [40].